Retatrutide is a newly developed drug that acts as a potent GLP-1 receptor activator. This breakthrough treatment holds significant potential for controlling type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide boosts insulin secretion and reduces glucagon release, leading to improved glycemic control. Clinical trials have dem… Read More